inositol has been researched along with Hirsutism in 7 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
Hirsutism: A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this retrospective study was to evaluate the effects of a long-term treatment with α-lipoic acid (ALA) combined with myo-inositol (MI) on clinical and metabolic features of women with polycystic ovary syndrome (PCOS)." | 7.96 | Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. ( Fidecicchi, T; Fruzzetti, F; Gambacciani, M; Palla, G, 2020) |
| "Our study showed that both myo-inositol (MI-PG) and D-chiro inositol (DCI-PG) treatments are able to significantly improve the regularity of the menstrual cycle, the Acne Score, the endocrine and metabolic parameters and the insulin-resistence in young, overweight, PCOS patients." | 5.20 | Myo-inositol vs. D-chiro inositol in PCOS treatment. ( Ciotta, L; Formuso, C; Stracquadanio, M, 2015) |
| "This new myo-inositol, monacolin K and lipoic acid association contains appropriate substances to contrast various etiopathogenic elements responsible for the onset of PCOS and the symptoms of hyperandrogenism and dyslipidemia related to it." | 5.20 | Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association. ( Cappelli, V; De Leo, V; Di Sabatino, A; Massaro, MG; Morgante, G, 2015) |
| "The aim of this retrospective study was to evaluate the effects of a long-term treatment with α-lipoic acid (ALA) combined with myo-inositol (MI) on clinical and metabolic features of women with polycystic ovary syndrome (PCOS)." | 3.96 | Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome. ( Fidecicchi, T; Fruzzetti, F; Gambacciani, M; Palla, G, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Morgante, G | 2 |
| Massaro, MG | 2 |
| Di Sabatino, A | 2 |
| Cappelli, V | 2 |
| De Leo, V | 2 |
| Fruzzetti, F | 1 |
| Fidecicchi, T | 1 |
| Palla, G | 1 |
| Gambacciani, M | 1 |
| Advani, K | 1 |
| Batra, M | 1 |
| Tajpuriya, S | 1 |
| Gupta, R | 1 |
| Saraswat, A | 1 |
| Nagar, HD | 1 |
| Makwana, L | 1 |
| Kshirsagar, S | 1 |
| Kaul, P | 1 |
| Ghosh, AK | 1 |
| Pradhan, S | 1 |
| Mehta, A | 1 |
| Jaiswal, A | 1 |
| Nakhate, KT | 1 |
| Kamdi, S | 1 |
| Formuso, C | 1 |
| Stracquadanio, M | 1 |
| Ciotta, L | 1 |
| Minozzi, M | 1 |
| D'Andrea, G | 1 |
| Unfer, V | 1 |
| Zacchè, MM | 1 |
| Caputo, L | 1 |
| Filippis, S | 1 |
| Zacchè, G | 1 |
| Dindelli, M | 1 |
| Ferrari, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Treatment of Functional Ovarian Cyst Randomised Clinical Trial[NCT05244811] | Phase 3 | 60 participants (Anticipated) | Interventional | 2022-02-20 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for inositol and Hirsutism
| Article | Year |
|---|---|
Therapeutic approach for metabolic disorders and infertility in women with PCOS.
Topics: Androgen Antagonists; Anovulation; Clomiphene; Contraceptives, Oral, Hormonal; Female; Gonadotropins | 2018 |
3 trials available for inositol and Hirsutism
| Article | Year |
|---|---|
Myo-inositol vs. D-chiro inositol in PCOS treatment.
Topics: Acne Vulgaris; Adult; Double-Blind Method; Female; Hirsutism; Humans; Inositol; Insulin Resistance; | 2015 |
Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
Topics: Adult; Antioxidants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyslipidemias; Fem | 2015 |
Treatment of hirsutism with myo-inositol: a prospective clinical study.
Topics: Adult; Blood Glucose; Cholesterol; Female; Gonadal Steroid Hormones; Hirsutism; Humans; Inositol; In | 2008 |
3 other studies available for inositol and Hirsutism
| Article | Year |
|---|---|
Long-term treatment with α-lipoic acid and myo-inositol positively affects clinical and metabolic features of polycystic ovary syndrome.
Topics: Adult; Body Mass Index; Female; Hirsutism; Humans; Inositol; Insulin Resistance; Organ Size; Ovary; | 2020 |
Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study.
Topics: Adult; Antioxidants; Body Mass Index; Body Weight; Combined Modality Therapy; Dietary Supplements; F | 2020 |
Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
Topics: Acne Vulgaris; Adult; Drug Administration Schedule; Female; Hirsutism; Homeostasis; Humans; Inositol | 2009 |